

Artificial Intelligence (AI) in Drug Discovery Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
The AI in Drug Discovery market is experiencing significant growth, driven by advancements in computational methods and increasing demand for faster drug development. Estimated to reach approximately $5.4 billion by 2026, the market is characterized by a focus on predictive analytics, machine learning, and personalized medicine, enhancing research efficiency and costeffectiveness. Request Sample Report
◍ IBM
◍ Microsoft
◍ NVIDIA Corporation
◍ Atomwise, Inc.
◍ Deep Genomics
◍ Cloud Pharmaceuticals
◍ Insilico Medicine
◍ BenevolentAI
◍ Exscientia
◍ Cyclica
◍ BIOAGE
◍ Numerate
◍ NuMedii
◍ Envisagenics
◍ twoXAR
◍ OWKIN, Inc.
◍ XtalPi
The AI in Drug Discovery Market features companies like IBM, Microsoft, Google, and NVIDIA leveraging AI for data analysis, drug design, and predictive modeling. Startups like Atomwise and Insilico Medicine focus on compound screening and biomarker identification, accelerating discovery. Notable revenues include IBM's $57 billion and NVIDIA's $26.9 billion. Request Sample Report
◍ Pharmaceutical & Biotechnology Companies ◍ Contract Research Organizations
◍ Research Centers and Academic & Government Institutes
Software
Services
Request Sample Report
Request Sample Report
$ X Billion USD